4//SEC Filing
LAROSA JOSEPH J 4
Accession 0001968202-24-000135
CIK 0000872589other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:02 PM ET
Size
9.7 KB
Accession
0001968202-24-000135
Insider Transaction Report
Form 4
LAROSA JOSEPH J
SVP Gen Counsel and Secretary
Transactions
- Tax Payment
Common Stock
2024-12-09$787.00/sh−492$387,204→ 30,777 total - Award
Common Stock
2024-12-06+2,332→ 31,269 total - Award
Non-Qualified Stock Option (right to buy)
2024-12-06+8,981→ 8,981 totalExercise: $771.64Exp: 2034-12-06→ Common Stock (8,981 underlying)
Holdings
- 9,000(indirect: By 2024 GRAT)
Common Stock
- 371(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.
- [F2]The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001238303
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 4:02 PM ET
- Size
- 9.7 KB